Research paperPleasure and discipline in the uses of Ritalin (cas 113-45-1)
-
Add time:08/21/2019 Source:sciencedirect.com
BackgroundThe stimulant drug methylphenidate, otherwise known as Ritalin, is the mainstay of treatment for Attention Deficit Hyperactivity Disorder and is the most common psychotropic medication prescribed to children. Whilst psychiatric discourse presents it as a safe and effective treatment, critics point out its similarity to drugs like cocaine and describe it as “legalised speed”. This article examines the ambivalent identity of Ritalin as both benign medicine and dangerous drug.
We also recommend Trading Suppliers and Manufacturers of Ritalin (cas 113-45-1). Pls Click Website Link as below: cas 113-45-1 suppliers
Prev:A sensitive LC–MS/MS method to quantify METHYLERGONOVINE (cas 113-42-8) in human plasma and its application to a pharmacokinetic study
Next:Case ReportMethylphenidate (Ritalin (cas 113-45-1))-associated Cataract and Glaucoma) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Case ReviewIllicit intravenous use of methylphenidate (Ritalin (cas 113-45-1)) tablets: A review of four cases08/29/2019
- UpfrontMouse brains suggest Ritalin (cas 113-45-1) is addictive08/28/2019
- In BriefA shot of Ritalin (cas 113-45-1) could reverse a general anaesthesic08/27/2019
- Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate (Ritalin (cas 113-45-1)) and Dopamine☆08/26/2019
- Optimization of preparative electrophoretic chiral separation of Ritalin (cas 113-45-1) enantiomers08/25/2019
- Doing their jobs: mothering with Ritalin (cas 113-45-1) in a culture of mother-blame08/24/2019
- Dispositional, ecological and biological influences on adolescent tranquilizer, Ritalin (cas 113-45-1), and narcotics misuse08/23/2019
- Case ReportMethylphenidate (Ritalin (cas 113-45-1))-associated Cataract and Glaucoma08/22/2019
